Detalhe da pesquisa
1.
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
J Antimicrob Chemother
; 75(5): 1311-1320, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053203
2.
Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.
Acta Clin Belg
; 73(4): 275-280, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429390
3.
Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.
Antiviral Res
; 75(2): 129-38, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17379323
4.
Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.
PLoS One
; 8(11): e80259, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244665
5.
Socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study.
J Int AIDS Soc
; 16: 18643, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24331754
6.
Association of haptoglobin phenotypes with the development of Kaposi's sarcoma in HIV patients.
Arch Dermatol Res
; 303(10): 763-9, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748360
7.
Viral load assay sensitivity and low level viremia in HAART treated HIV patients.
J Clin Virol
; 47(4): 335-9, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20138803
8.
Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
Virology
; 379(2): 213-22, 2008 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-18692212
9.
Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
J Med Virol
; 79(9): 1254-60, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17607772
10.
Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.
J Acquir Immune Defic Syndr
; 35(5): 473-83, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15021312